What This Bill Does · Plain English
Summary
Plain-English summary not yet available for this bill. Check back after our next analysis run.
Action Timeline
2026-02-05
Referred to the House Committee on Energy and Commerce.
2026-02-05
Introduced in House
2026-02-05
Introduced in House
Frequently Asked Questions
Did HR.7407 pass?
HR.7407 is still alive. Current stage: COMMITTEE. Pass likelihood: pending.
Who sponsored HR.7407?
HR.7407 was sponsored by Frank Pallone (D-New Jersey).
Full Bill Text
119 HR 7407 IH: Prohibiting Tianeptine and Other Dangerous Products Act of 2026 U.S. House of Representatives 2026-02-05 text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. I 119th CONGRESS 2d Session H. R. 7407 IN THE HOUSE OF REPRESENTATIVES February 5, 2026 Mr. Pallone introduced the following bill; which was referred to the Committee on Energy and Commerce A BILL To amend the Federal Food, Drug, and Cosmetic Act to establish new prohibited acts relating to dietary supplements. 1. Short title This Act may be cited as the Prohibiting Tianeptine and Other Dangerous Products Act of 2026 . 2. New prohibited acts relating to dietary supplements (a) In general Section 301 of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 331 ) is amended by adding at the end the following: (jjj) The introduction or delivery for introduction into interstate commerce of any product marketed as a dietary supplement that does not meet the definition of a dietary supplement under section 201(ff). (kkk) The introduction or delivery for introduction into interstate commerce of a dietary supplement that has been prepared, packed, or held using the assistance of, or at the direction of, a person debarred under section 306. . (b) New import exclusion Section 801(a) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 381(a) ) is amended in paragraph (3) of the third sentence, by striking section 301(ll) and inserting paragraph (ll), (jjj), or (kkk) of section 301 . (c) New seizure authorities Section 304 of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 334 ) is amended— (1) in subsection (a)(1), in the first sentence, by striking section section 301(ll), 404, or 505 and inserting paragraph (ll), (jjj), or (kkk) of section 301, section 404, or section 505 ; and (2) in subsection (d)(1), in the first sentence, by inserting , or product in violation of paragraph (jjj) or (kkk) of section 301, after condemned under this section .
Loading intelligence layer…